Skip to main content
Figure 3 | Experimental Hematology & Oncology

Figure 3

From: A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC

Figure 3

Kaplan-Meier analysis of overall survival (OS) for BAALC , EVI1 and MN1 in training (left) and validation cohorts (right). Individual KM strata are color coded to depict favorable (F), intermediate (I), unfavorable (U) cytogenetic risk. The intermediate group is plotted in grey because it was re-stratified into low expressors (blue) and high expressors (red). cutoff points used in this validation study are BAALC expression −0.95 (derived from the 30th percentile in the training), EVI1 expression 0.987 (derived from a single short survival case in the training cohort), MN1 expression −0.76 (derived from the 30th percentile in the training).

Back to article page